Congenital heart defects (CHD) represent the most common congenital malformations globally and constitute a leading cause of neonatal mortality, with early maternal risk factors playing significant ...

OS of 8.9 months versus 5.8 months with trifluridine/tipiracil alone, supporting phase III ...

BioNTech and partner DualityBio are accelerating the development of their B7-H3 antibody-drug conjugate into a phase 3 trial for metastatic castration-resistant prostate cancer (mCRPC). | BioNTech and ...

Introduction Maintaining normal fluid status is critical to health and well-being. Older people are vulnerable to abnormal fluid status and associated complications, morbidity and mortality. Care home ...

An international study led by researchers from the Sant Pau Research Institute (IR Sant Pau) shows that advanced use of magnetic resonance imaging (MRI) allows much more accurate identification of ...

Discusses Positive Phase 3 PROPEL 3 Results for Infigratinib in Children With Achondroplasia February 12, 2026 8:00 ...

Amarin Corp (NASDAQ: AMRN) held its fourth-quarter earnings conference call on Wednesday. Below is the complete transcript from the call. This content is powered by Benzinga APIs. For comprehensive ...

Amarin Corporation plc (NASDAQ: AMRN) Q4 2025 Earnings Call Transcript February 25, 2026 Amarin Corporation plc misses on earnings expectations. Reported EPS is $-0.00294 EPS, expectations were $0.07.

In A Nutshell Brain scans of 110 adults show that in people with age-related hearing loss, certain brain regions can’t maintain adequate activity levels as tissue shrinks A memory-related region ...

Background Cardiovascular disease (CVD) is the leading cause of mortality worldwide, while depression is highly prevalent in this patient population and has long been regarded as an independent risk ...